Evidence map›Paper›PMID 32722709›Full record

ArticlePLoS neglected tropical diseases2020

Measuring health related quality of life for dengue patients in Iquitos, Peru.

William H Elson, Amy R Riley-Powell, Amy C Morrison, Esther E Gotlieb, Erik J Groessl, Jhonny J Cordova, J Esther Rios, W Lorena Quiroz, Alfonso S Vizcarra, Robert C Reiner and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

William H ElsonDepartment of Entomology and Nematology, University of California Davis, Davis, California, United States of America.ORCID 0000-0002-8630-1378
Amy R Riley-PowellDepartment of Global Community Health and Behavioral Sciences, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America.
Amy C MorrisonDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine University of California Davis, Davis, California, United States of America.
Esther E GotliebDepartment of Global Community Health and Behavioral Sciences, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America.
Erik J GroesslDepartment of Family Medicine and Public Health, University of California San Diego and VA San Diego Medical Center, San Diego, California, United States of America.
Jhonny J CordovaDepartment of Entomology and Nematology, University of California Davis, Davis, California, United States of America.
J Esther RiosVirology and Emerging Infections Department, United States Naval Medical Research, Washington DC United States of America and Lima/Iquitos, Peru.
W Lorena QuirozVirology and Emerging Infections Department, United States Naval Medical Research, Washington DC United States of America and Lima/Iquitos, Peru.
Alfonso S VizcarraDepartment of Entomology and Nematology, University of California Davis, Davis, California, United States of America.
Robert C ReinerDepartment of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, Washington, United States of America.
Christopher M BarkerDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine University of California Davis, Davis, California, United States of America.ORCID 0000-0002-7941-346X
Gonzalo M Vazquez-ProkopecDepartment of Environmental Sciences, Emory University, Atlanta, Georgia, United States of America.
Thomas W ScottDepartment of Entomology and Nematology, University of California Davis, Davis, California, United States of America.ORCID 0000-0003-2947-8123
Alan L RothmanInstitute for Immunology and Informatics and Department of Cell and Molecular Biology, University of Rhode Island, Providence, Rhode Island, United States of America.ORCID 0000-0002-4064-6848
John P ElderGraduate School of Public Health, San Diego State University, San Diego, California, United States of America.
Valerie A Paz-SoldanDepartment of Global Community Health and Behavioral Sciences, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America.
University of California, Davis · USTulane University · USUnited States Naval Medical Research Unit SOUTH · PEEmory University · USSan Diego State University · USUniversity of California San Diego Medical Center · USUniversity of Rhode Island · USUniversity of Washington · US

Funding

Surveillance Core (B)P01AI098670 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SCOTT, THOMAS WALLACE · 2014 to 2018
$7.9M
NIAID NIH HHS P01 AI098670Wellcome TrustWellcome Trust 212712/Z/18/Z
6 · The paper itself

Abstract

Previous studies measuring the health-related quality of life (HRQoL) of individuals with dengue focused on treatment seeking populations. However, the vast majority of global dengue cases are unlikely to be detected by health systems. Representative measurements of HRQoL should therefore include patients with disease not likely to trigger treatment-seeking behavior. This study based in Iquitos, Peru used the Quality of Wellbeing Scale-Self Administered, a survey that enquires about not only physical health, but also psychological health, self-care, mobility, and usual social activities, and rates HRQoL between 0 (death) and 1 (optimum function), to evaluate the impact of dengue on HRQoL. In order to enroll treatment and non treatment-seeking participants, three modalities of participant recruitment were used. In addition to clinic and community-based febrile surveillance, a contact-cluster methodology was also employed to identify infected individuals less likely to seek treatment. We measured changes in HRQoL and identified common areas of health impairment in 73 virologically confirmed dengue cases at 3 time points during the participant's illness; the early-acute (days 0-6 post symptom onset), late-acute (days 7-20), and convalescent illness phases (days 21 +). Participants reported HRQoL related impairments at significantly higher frequency during the early-acute versus convalescent illness phase (Fisher's exact: P<0.01). There was substantial heterogeneity in scores during each illness phase with median scores in the early-acute, late-acute and convalescent phases of 0.56 (IQR: 0.41-0.64), 0.70 (IQR: 0.57-0.94), and 1 (IQR: 0.80-1.00), respectively. In all illness phases participants recruited in clinics had on average the lowest HRQoL scores where as those recruited in the contact clusters had the highest. Only 1 individual who was recruited in the contact-clusters had no reduction in HRQoL score during their illness. These data illustrate that dengue should be considered as a disease that may have significant implications for not only physical health but also psychological health and social functioning. The impact of dengue on the HRQoL of non-treatment-seeking individuals, although lower than the impact among treatment-seeking individuals, is not necessarily trivial.

Indexed as

Quality of LifeAdolescentAdultDengueFemaleHumansMalePeruYoung Adult

Identifiers

PMID32722709
PMCPMC7413550
OpenAlexW3046181510

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.